Corvus Pharmaceuticals
CRVS
$1.58
Share price
8.97%
Change (1 day)
42.34%
Change (1 year)
Categories
Corvus Pharmaceuticals (CRVS) - Cash on Hand
Cash on Hand as of December 2023 : $27.14 M
According to Corvus Pharmaceuticals
's latest financial reports the company has $27.14 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Corvus Pharmaceuticals - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $42.3 M | -39.09% |
| 2021-12-31 | $69.45 M | 56.92% |
| 2020-12-31 | $44.25 M | -43.24% |
| 2019-12-31 | $77.98 M | -31.95% |
| 2018-12-31 | $0.11 B | 27.25% |
| 2017-12-31 | $90.05 M | -33.24% |
| 2016-12-31 | $0.13 B | 42.92% |
| 2015-12-31 | $94.38 M | 654.06% |
| 2014-12-31 | $12.51 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 666.83% | 🇺🇸 USA |